Astec Lifesciences hit a new lifetime high today at Rs.770, going up 11.5% and volumes surged almost 3 times the 2-week average. Its market cap stands at Rs.1450 crore.
The stock is euphoric after it posted a very good set of numbers for Q4FY18. The company’s net profit showed a 102% (YoY) growth at Rs.17 crore on a 49% rise in net sales at Rs.128 crore – the highest in last five quarters.
EBITDA was up 88% at Rs.31 crore and margins improved dramatically from 19.09% to 24.30%.